Cargando…

Relationship between Cerebrospinal Fluid Matrix Metalloproteinases Levels and Brain Amyloid Deposition in Mild Cognitive Impairment

This study aimed to explore whether cerebrospinal fluid (CSF) levels of matrix metalloproteinases (MMPs), and their inhibitors (TIMPs) were associated with brain amyloid deposition, cortical glucose metabolism, and white matter lesions (WMLs) in individuals with amnestic mild cognitive impairment (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki, Yuuki, Kimura, Noriyuki, Aso, Yasuhiro, Yabuuchi, Kenichi, Aikawa, Miki, Matsubara, Etsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533797/ https://www.ncbi.nlm.nih.gov/pubmed/34680129 http://dx.doi.org/10.3390/biom11101496

Ejemplares similares

Association of Modifiable Lifestyle Factors With Cortical Amyloid Burden and Cerebral Glucose Metabolism in Older Adults With Mild Cognitive Impairment
por: Kimura, Noriyuki, et al.
Publicado: (2020)

Association between objectively measured walking steps and sleep in community-dwelling older adults: A prospective cohort study
por: Kimura, Noriyuki, et al.
Publicado: (2020)

Modifiable Lifestyle Factors and Cognitive Function in Older People: A Cross-Sectional Observational Study
por: Kimura, Noriyuki, et al.
Publicado: (2019)

“Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report”
por: Aso, Yasuhiro, et al.
Publicado: (2018)

Brain Perfusion in Corticobasal Syndrome with Progressive Aphasia
por: Abe, Yoshitake, et al.
Publicado: (2016)

Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy
por: Vervuurt, Marc, et al.
Publicado: (2023)

Cerebrospinal fluid cytokines, matrix metalloproteinases, HIV, and tuberculous meningitis
por: Tin, Sim Sai, et al.
Publicado: (2015)

Lifestyle factors that affect cognitive function–a longitudinal objective analysis
por: Kimura, Noriyuki, et al.
Publicado: (2023)

Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis
por: Green, Justin A., et al.
Publicado: (2009)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
por: Minta, Karolina, et al.
Publicado: (2020)

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2020)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas
por: Wong, Eric T, et al.
Publicado: (2008)

Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction
por: Thibert, Kathryn A., et al.
Publicado: (2012)

Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis
por: Rai, Dheeraj, et al.
Publicado: (2014)

Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients
por: Castellazzi, Massimiliano, et al.
Publicado: (2018)

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis
por: Mailankody, Sharada, et al.
Publicado: (2017)

Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus
por: Lind, Liza, et al.
Publicado: (2019)

Modified platelet deposition on matrix metalloproteinase 13 digested collagen I
por: Howes, J.‐M., et al.
Publicado: (2015)

Temporal Changes in Brain Perfusion in Neuronal Intranuclear Inclusion Disease
por: Ataka, Takuya, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein-antibody-associated Disorder Presenting with Corticomeningeal Encephalitis Prior to the Onset of Optic Neuritis
por: Ataka, Takuya, et al.
Publicado: (2021)

Heteromers of amyloid precursor protein in cerebrospinal fluid
por: Cuchillo-Ibañez, Inmaculada, et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy
por: Sembill, Jochen A, et al.
Publicado: (2023)

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
por: Kaiser, Elmar, et al.
Publicado: (2011)

Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer’s disease
por: Yoshida, Kenta, et al.
Publicado: (2020)

Changes in objectively measured lifestyle factors during the COVID-19 pandemic in community-dwelling older adults
por: Ataka, Takuya, et al.
Publicado: (2022)

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
por: Gisslén, Magnus, et al.
Publicado: (2009)

PET Tau and Amyloid-β Burden in Mild Alzheimer’s Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
por: Koychev, Ivan, et al.
Publicado: (2017)

Elevation of Matrix Metalloproteinase-9 Level in Cerebrospinal Fluid of Tick-Borne Encephalitis Patients Is Associated with IgG Extravassation and Disease Severity
por: Kang, Xiaoping, et al.
Publicado: (2013)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
por: Wu, Liyong, et al.
Publicado: (2012)

Medroxyprogesterone Acetate Impairs Amyloid Beta Degradation in a Matrix Metalloproteinase-9 Dependent Manner
por: Porter, Keyana N., et al.
Publicado: (2020)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
por: Kim, Hyung-Ji, et al.
Publicado: (2022)

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid
por: Bjerke, Maria, et al.
Publicado: (2010)

Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis
por: Banerjee, Gargi, et al.
Publicado: (2021)

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
por: Delaby, Constance, et al.
Publicado: (2022)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fg3ss90am9pmuqs4i8ah36669h